1-(benzo[d][1,3]dioxol-5-yl)-2-bromopropan-1-one CAS52190-28-0

Lihe Pharmaceutical Technology (Wuhan) Co., Ltd, The main pharmaceutical intermediates, APIs mainly produce and develop ingredients. The company has strong technical force, advanced equipment, strict quality management system and excellent after-sales service. Over the years, we have managed the entire trade process strictly, paying attention to every detail, providing customers with a full range of services such as product procurement, R&D, quality control, logistics management and so on to become trusted partners for customers. Our company offers variety of products which can meet your multifarious demands. We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers. Our company is sincerely willing to cooperate with enterprises from all over the world in order to realize a win-win situation since the trend of economic globalization has developed with anirresistible force. Products are exported to Russia, the United States, the United Kingdom, the Czech Republic, the Netherlands, Australia and other overseas regions. 80% of them are exported to Europe, the Middle East and America, and 20% to other regions. With many years of experience, I have accumulated a lot of product knowledge. The product and market to our company builds the best confidence for our customers.